BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1003239 OCCS(=O)(=O)c1cccc(OC[C@@H](O)CNC2COC3(C2)CCN(CC3)S(=O)(=O)c2ccc3ccccc3c2)c1 InChI=1S/C29H36N2O8S2/c32-14-15-40(34,35)27-7-3-6-26(17-27)38-21-25(33)19-30-24-18-29(39-20-24)10-12-31(13-11-29)41(36,37)28-9-8-22-4-1-2-5-23(22)16-28/h1-9,16-17,24-25,30,32-33H,10-15,18-21H2/t24?,25-/m0/s1 VBJKDHPUWGDJCV-BBMPLOMVSA-N 484044 (2S)-1-(3-(2- hydroxyethylsulfonyl) phenoxy)-3-(8- (naphthalen-2- ylsulfonyl)-1-oxa-8- azaspiro[4.5]decan-3- ylamino)propan-2-ol::US10927123, Compound 5 Beta-3 adrenergic receptor Homo sapiens 33310 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484044 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484044&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225033 443553127 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003240 OCCS(=O)(=O)c1cccc(OC[C@@H](O)CN[C@H]2COC3(C2)CCN(CC3)S(=O)(=O)c2cnc3ccccc3c2)c1 InChI=1S/C28H35N3O8S2/c32-12-13-40(34,35)25-6-3-5-24(15-25)38-20-23(33)17-29-22-16-28(39-19-22)8-10-31(11-9-28)41(36,37)26-14-21-4-1-2-7-27(21)30-18-26/h1-7,14-15,18,22-23,29,32-33H,8-13,16-17,19-20H2/t22-,23+/m1/s1 VZYAQGTUMRXLOW-PKTZIBPZSA-N 484045 (S)-1-(3-(2- hydroxyethylsulfonyl) phenoxy)-3-(R)-8- (quinolin-3-ylsulfonyl)- 1-oxa-8- azaspiro[4.5]decan-3- ylamino)propan-2-ol::US10927123, Compound 88 Beta-3 adrenergic receptor Homo sapiens 25120 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484045 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484045&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225036 443553128 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003241 NC(=O)CS(=O)(=O)c1cccc(OC[C@@H](O)CN[C@H]2COC3(C2)CCN(CC3)S(=O)(=O)c2cnc3ccccc3c2)c1 InChI=1S/C28H34N4O8S2/c29-27(34)19-41(35,36)24-6-3-5-23(13-24)39-18-22(33)15-30-21-14-28(40-17-21)8-10-32(11-9-28)42(37,38)25-12-20-4-1-2-7-26(20)31-16-25/h1-7,12-13,16,21-22,30,33H,8-11,14-15,17-19H2,(H2,29,34)/t21-,22+/m1/s1 CJNUPIPMYICUTD-YADHBBJMSA-N 484046 2-(3-((S)-2-hydroxy-3- ((R)-8-(quinolin-3- ylsulfonyl)-1-oxa-8- azaspiro[4.5]decan-3- ylamino)propoxy)phenyl sulfonl)acetamide::US10927123, Compound 123 Beta-3 adrenergic receptor Homo sapiens 53170 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484046 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484046&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225034 443553129 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003242 OCC1(CC1)S(=O)(=O)c1cccc(OC[C@@H](O)CN[C@H]2COC3(C2)CCN(CC3)S(=O)(=O)c2cnc3ccccc3c2)c1 InChI=1S/C30H37N3O8S2/c34-21-30(8-9-30)42(36,37)26-6-3-5-25(15-26)40-20-24(35)17-31-23-16-29(41-19-23)10-12-33(13-11-29)43(38,39)27-14-22-4-1-2-7-28(22)32-18-27/h1-7,14-15,18,23-24,31,34-35H,8-13,16-17,19-21H2/t23-,24+/m1/s1 ZUYFAHYJNMCDJP-RPWUZVMVSA-N 484047 (S)-1-(3-(1- (hydroxymethyl) cyclopropylsulfonyl) phenoxy)- 3-((R)-8-(quinolin-3- ylsulfonyl)-1-oxa-8- azaspiro[4.5]decan-3- ylamino)propan-2-ol::US10927123, Compound 136 Beta-3 adrenergic receptor Homo sapiens 18830 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484047 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484047&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225035 443553130 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003243 CN1CCOc2ncc(cc12)S(=O)(=O)N1CCC2(C[C@H](CO2)NC[C@H](O)COc2cccc(c2)S(=O)(=O)C2CC2)CC1 InChI=1S/C28H38N4O8S2/c1-31-11-12-38-27-26(31)14-25(17-30-27)42(36,37)32-9-7-28(8-10-32)15-20(18-40-28)29-16-21(33)19-39-22-3-2-4-24(13-22)41(34,35)23-5-6-23/h2-4,13-14,17,20-21,23,29,33H,5-12,15-16,18-19H2,1H3/t20-,21+/m1/s1 BPSWQDAREMZHQC-RTWAWAEBSA-N 484048 (S)-1-(3-(cyclopropyl- sulfonyl)phenoxy)- 3-((R)-8-(l-methyl- 2,3-dihydro-1H-pyrido [2,3-b][1,4]oxazin-7- ylsulfonyl)-1-oxa-8- azaspiro[4.5]decan-3- ylamino)propan-2-ol::US10927123, Compound 154 Beta-3 adrenergic receptor Homo sapiens 17500 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484048 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484048&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225031 443553131 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003244 CCOc1ccc(cc1S(=O)(=O)N1CCC2(C[C@H](CO2)NC[C@H](O)COc2cccc(c2)S(=O)(=O)C(F)(F)CO)CC1)-c1ccc(CN)cc1 InChI=1S/C34H43F2N3O9S2/c1-2-46-31-11-10-26(25-8-6-24(19-37)7-9-25)16-32(31)50(44,45)39-14-12-33(13-15-39)18-27(21-48-33)38-20-28(41)22-47-29-4-3-5-30(17-29)49(42,43)34(35,36)23-40/h3-11,16-17,27-28,38,40-41H,2,12-15,18-23,37H2,1H3/t27-,28+/m1/s1 POEMYWADWSEZSB-IZLXSDGUSA-N 484049 (S)-1-((R)-8-(4'- (aminomethyl)-4- ethoxybiphenyl-3- ylsulfonyl)-l-oxa-8- azaspiro[4.5]decan-3- ylamino)-3-(3-(1,1- difluoro-2- hydroxyethylsulfonyl) phenoxy)propan-2-ol::US10927123, Compound 161 Beta-3 adrenergic receptor Homo sapiens 21140 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484049 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484049&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225032 443553132 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003245 CCOc1ccc(cc1S(=O)(=O)N1CCC2(C[C@@H](CO2)NC[C@H](O)COc2cccc(c2)S(=O)(=O)C2(CO)CC2)CC1)-c1ccc(CN)cc1 InChI=1S/C36H47N3O9S2/c1-2-46-33-11-10-28(27-8-6-26(21-37)7-9-27)18-34(33)50(44,45)39-16-14-35(15-17-39)20-29(23-48-35)38-22-30(41)24-47-31-4-3-5-32(19-31)49(42,43)36(25-40)12-13-36/h3-11,18-19,29-30,38,40-41H,2,12-17,20-25,37H2,1H3/t29-,30-/m0/s1 VUHKCOWMKWKROS-KYJUHHDHSA-N 484050 (S)-1-((S)-8-(4'- (aminomethyl)-4- ethoxybiphenyl-3- ylsulfonyl)-l-oxa-8- azaspiro[4.5]decan-3- ylamino)-3-(3-(1- (hydroxymethyl) cyclopropylsulfonyl) phenoxy)propan-2-ol::US10927123, Compound 163 Beta-3 adrenergic receptor Homo sapiens 17310 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484050 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484050&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225559 443553133 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003246 NCc1ccc(cc1)-c1ccc(F)c(c1)S(=O)(=O)N1CCC2(C[C@H](CO2)NC[C@H](O)COc2cccc(c2)S(=O)(=O)C2(CO)CC2)CC1 InChI=1S/C34H42FN3O8S2/c35-31-9-8-26(25-6-4-24(19-36)5-7-25)16-32(31)48(43,44)38-14-12-33(13-15-38)18-27(21-46-33)37-20-28(40)22-45-29-2-1-3-30(17-29)47(41,42)34(23-39)10-11-34/h1-9,16-17,27-28,37,39-40H,10-15,18-23,36H2/t27-,28+/m1/s1 DBAGNVZJAXBPJQ-IZLXSDGUSA-N 484051 (S)-1-((R)-8-(4'- (aminomethyl)-4- fluorobiphenyl-3- ylsulfonyl)-1-oxa-8- azaspiro[4.5]decan-3- ylamino)-3-(3-(1- (hydroxymethyl) cyclopropylsulfonyl) phenoxy)propan-2-ol::US10927123, Compound 169 Beta-3 adrenergic receptor Homo sapiens 17470 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484051 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484051&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225565 443553134 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003247 COc1ccc(cc1-c1ccc(cc1)C1(N)CC1)S(=O)(=O)N1CCC2(C[C@H](CO2)NC[C@H](O)COc2cccc(c2)S(=O)(=O)C2(CO)CC2)CC1 InChI=1S/C37H47N3O9S2/c1-47-34-10-9-32(20-33(34)26-5-7-27(8-6-26)37(38)13-14-37)51(45,46)40-17-15-35(16-18-40)21-28(23-49-35)39-22-29(42)24-48-30-3-2-4-31(19-30)50(43,44)36(25-41)11-12-36/h2-10,19-20,28-29,39,41-42H,11-18,21-25,38H2,1H3/t28-,29+/m1/s1 RZPQETZWVOXDNP-WDYNHAJCSA-N 484052 (S)-1-((R)-8-(4'-(1- aminocyclopropyl)-6- methoxybiphenyl-3- ylsulfonyl)-1-oxa-8- azaspiro[4.5]decan-3- ylamino)-3-(3-(1- (hydroxymethyl) cyclopropylsulfonyl (phenoxy)propan-2-ol::US10927123, Compound 199 Beta-3 adrenergic receptor Homo sapiens 25010 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484052 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484052&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225563 443553135 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003248 NCCc1ccc(cc1)-c1cccc(c1)S(=O)(=O)N1CCC2(C[C@@H](CO2)NC[C@H](O)COc2cccc(c2)S(=O)(=O)C(F)(F)CO)CC1 InChI=1S/C33H41F2N3O8S2/c34-33(35,23-39)47(41,42)30-5-2-4-29(18-30)45-22-28(40)20-37-27-19-32(46-21-27)12-15-38(16-13-32)48(43,44)31-6-1-3-26(17-31)25-9-7-24(8-10-25)11-14-36/h1-10,17-18,27-28,37,39-40H,11-16,19-23,36H2/t27-,28-/m0/s1 OTTAXHQDRZQBSM-NSOVKSMOSA-N 484053 (S)-1-((S)-8-(4'-(2- aminoethyl)biphenyl-3- ylsulfonyl)-1-oxa-8- azaspiro[4.5]decan-3- ylamino)-3-(3-(1,1- difluoro-2- hydroxyethylsulfonyl) phenoxy)propan-2-ol::US10927123, Compound 210 Beta-3 adrenergic receptor Homo sapiens 22430 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484053 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484053&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225561 443553136 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003249 NCCc1ccc(cc1)-c1cccc(c1)S(=O)(=O)N1CCC2(C[C@@H](CO2)NC[C@H](O)COc2cccc(c2)S(=O)(=O)C2(CO)CC2)CC1 InChI=1S/C35H45N3O8S2/c36-16-11-26-7-9-27(10-8-26)28-3-1-6-33(19-28)48(43,44)38-17-14-34(15-18-38)21-29(23-46-34)37-22-30(40)24-45-31-4-2-5-32(20-31)47(41,42)35(25-39)12-13-35/h1-10,19-20,29-30,37,39-40H,11-18,21-25,36H2/t29-,30-/m0/s1 MBIXCUIOHLJBGG-KYJUHHDHSA-N 484054 (S)-1-((S)-8-(4'-(2- aminoethyl)biphenyl-3- ylsulfonyl)-l-oxa-8- azaspiro[4.5]decan-3- ylamino)-3-(3-(1- (hydroxymelhyl) cyclopropylsulfonyl) phenoxy)propan-2-ol::US10927123, Compound 211 Beta-3 adrenergic receptor Homo sapiens 26180 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484054 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484054&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225560 443553137 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003250 NC1(CC1)c1ccc(cc1)-c1cc(ccc1F)S(=O)(=O)N1CCC2(C[C@H](CO2)NC[C@H](O)COc2cccc(c2)S(=O)(=O)C2(CO)CC2)CC1 InChI=1S/C36H44FN3O8S2/c37-33-9-8-31(19-32(33)25-4-6-26(7-5-25)36(38)12-13-36)50(45,46)40-16-14-34(15-17-40)20-27(22-48-34)39-21-28(42)23-47-29-2-1-3-30(18-29)49(43,44)35(24-41)10-11-35/h1-9,18-19,27-28,39,41-42H,10-17,20-24,38H2/t27-,28+/m1/s1 HXKANHZDNNIVBW-IZLXSDGUSA-N 484055 (S)-1-((R)-8-(4'-(1- aminocyclopropyl)-6- fluorobiphenyl-3- ylsulfonyl)-1-oxa-8- azaspiro[4.5]decan-3- ylamino)-3-(3-(1- (hydroxymethyl) cyclopropylsulfonyl) phenoxy)propan-2-ol::US10927123, Compound 217 Beta-3 adrenergic receptor Homo sapiens 28430 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484055 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484055&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225038 443553138 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003251 COc1ccc(cc1-c1ccc(cc1)C1(N)CC1)S(=O)(=O)N1CCC2(C[C@@H](CO2)NC[C@H](O)COc2cccc(c2)S(=O)(=O)C2(CO)CC2)CC1 InChI=1S/C37H47N3O9S2/c1-47-34-10-9-32(20-33(34)26-5-7-27(8-6-26)37(38)13-14-37)51(45,46)40-17-15-35(16-18-40)21-28(23-49-35)39-22-29(42)24-48-30-3-2-4-31(19-30)50(43,44)36(25-41)11-12-36/h2-10,19-20,28-29,39,41-42H,11-18,21-25,38H2,1H3/t28-,29-/m0/s1 RZPQETZWVOXDNP-VMPREFPWSA-N 484056 (S)-1-((S)-8-(4'-(1- aminocyclopropyl)-6- methoxybiphenyl-3- ylsulfonyl)-1-oxa-8- azaspiro[4.5]decan-3- ylamino)-3-(3-(1- (hydroxymethyl) cyclopropylsulfonyl) phenoxy)propan-2-ol::US10927123, Compound 225 Beta-3 adrenergic receptor Homo sapiens 33100 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484056 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484056&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225040 443553139 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003252 COc1ccc(cc1-c1ccc(CN)cc1)S(=O)(=O)N1CCC2(C[C@@H](CO2)NC[C@H](O)COc2cccc(c2)S(=O)(=O)C2CC2)CC1 InChI=1S/C34H43N3O8S2/c1-43-33-12-11-31(18-32(33)25-7-5-24(20-35)6-8-25)47(41,42)37-15-13-34(14-16-37)19-26(22-45-34)36-21-27(38)23-44-28-3-2-4-30(17-28)46(39,40)29-9-10-29/h2-8,11-12,17-18,26-27,29,36,38H,9-10,13-16,19-23,35H2,1H3/t26-,27-/m0/s1 RZYWIPZOLSCULT-SVBPBHIXSA-N 484057 (S)-1-((S)-8-(4'- (aminomethyl)-6- methoxybiphenyl-3- ylsulfonyl)-1-oxa-8- azaspiro[4.5]decan-3- ylamino)-3-(3- (cyclopropylsulfonyl) phenoxy)propan-2-ol::US10927123, Compound 227 Beta-3 adrenergic receptor Homo sapiens 17900 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484057 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484057&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225039 443553140 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003253 COc1cc(cc(c1)S(=O)(=O)N1CCC2(C[C@@H](CO2)NC[C@H](O)COc2cccc(c2)S(=O)(=O)C2CC2)CC1)-c1ccc(CN)cc1 InChI=1S/C34H43N3O8S2/c1-43-30-15-26(25-7-5-24(20-35)6-8-25)16-33(18-30)47(41,42)37-13-11-34(12-14-37)19-27(22-45-34)36-21-28(38)23-44-29-3-2-4-32(17-29)46(39,40)31-9-10-31/h2-8,15-18,27-28,31,36,38H,9-14,19-23,35H2,1H3/t27-,28-/m0/s1 RPZAVDKUZVJGBC-NSOVKSMOSA-N 484058 (S)-1-((S)-8-(4'- (aminomethyl)-5- methoxybiphenyl-3- ylsulfonyl)-1-oxa-8- azaspiro[4.5]decan-3- ylamino)-3-(3- (cyclopropylsulfonyl) phenoxy)propan-2-ol::US10927123, Compound 229 Beta-3 adrenergic receptor Homo sapiens 11580 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484058 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484058&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 139485458 443553141 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003254 CCOc1ccc(cc1S(=O)(=O)N1CCC2(C[C@@H](CO2)NC[C@H](O)COc2cccc(c2)S(=O)(=O)COC)CC1)-c1ccc(CN)cc1 InChI=1S/C34H45N3O9S2/c1-3-44-32-12-11-27(26-9-7-25(20-35)8-10-26)17-33(32)48(41,42)37-15-13-34(14-16-37)19-28(22-46-34)36-21-29(38)23-45-30-5-4-6-31(18-30)47(39,40)24-43-2/h4-12,17-18,28-29,36,38H,3,13-16,19-24,35H2,1-2H3/t28-,29-/m0/s1 MWQGFMMWRHXINT-VMPREFPWSA-N 484059 (S)-1-((S)-8-(4'- (aminomethyl)-4- ethoxybiphenyl-3- ylsulfonyl)-l-oxa-8- azaspiro[4.5]decan-3- ylamino)-3-(3- (methoxymethylsulfonyl) phenoxy)propan-2-ol::US10927123, Compound 230 Beta-3 adrenergic receptor Homo sapiens 14990 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484059 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484059&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225051 443553142 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003255 CCOc1ccc(cc1S(=O)(=O)N1CCC2(C[C@@H](CO2)NC[C@H](O)COc2cccc(c2)S(=O)(=O)C(C)C)CC1)-c1ccc(CN)cc1 InChI=1S/C35H47N3O8S2/c1-4-44-33-13-12-28(27-10-8-26(21-36)9-11-27)18-34(33)48(42,43)38-16-14-35(15-17-38)20-29(23-46-35)37-22-30(39)24-45-31-6-5-7-32(19-31)47(40,41)25(2)3/h5-13,18-19,25,29-30,37,39H,4,14-17,20-24,36H2,1-3H3/t29-,30-/m0/s1 YRGFWSXWUWTZSV-KYJUHHDHSA-N 484060 (S)-1-((S)-8-(4'- (aminomethyl)-4- ethoxybiphenyl-3- ylsulfonyl)-1-oxa-8- azaspiro[4.5]decan-3- ylamino)-3-(3- (isopropylsulfonyl) phenoxy)propan-2-ol::US10927123, Compound 232 Beta-3 adrenergic receptor Homo sapiens 16630 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484060 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484060&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225052 443553143 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003256 CC(F)S(=O)(=O)c1cccc(OC[C@@H](O)CN[C@H]2COC3(C2)CCN(CC3)S(=O)(=O)c2ccc3ncccc3c2)c1 InChI=1S/C28H34FN3O7S2/c1-20(29)40(34,35)25-6-2-5-24(15-25)38-19-23(33)17-31-22-16-28(39-18-22)9-12-32(13-10-28)41(36,37)26-7-8-27-21(14-26)4-3-11-30-27/h2-8,11,14-15,20,22-23,31,33H,9-10,12-13,16-19H2,1H3/t20?,22-,23+/m1/s1 SHAYHNRTJQKVNJ-LQKDOSGMSA-N 484061 (2S)-1-(3-(1- fluoroethylsulfonyl) phenoxy)-3-((R)-8- (quinolin-6-ylsulfonyl)- 1-oxa-8- azaspiro[4.5]decan-3- ylamino)propan-2-ol::US10927123, Compound 234 Beta-3 adrenergic receptor Homo sapiens 10190 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484061 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484061&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225053 443553144 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003257 CC(C)(C)NCc1ccc(cc1)-c1cccc(c1)S(=O)(=O)N1CCC2(C[C@@H](CO2)NC[C@H](O)COc2cccc(c2)S(=O)(=O)C2(CO)CC2)CC1 InChI=1S/C38H51N3O8S2/c1-36(2,3)40-23-28-10-12-29(13-11-28)30-6-4-9-35(20-30)51(46,47)41-18-16-37(17-19-41)22-31(25-49-37)39-24-32(43)26-48-33-7-5-8-34(21-33)50(44,45)38(27-42)14-15-38/h4-13,20-21,31-32,39-40,42-43H,14-19,22-27H2,1-3H3/t31-,32-/m0/s1 QCSNKQSIUIMGFB-ACHIHNKUSA-N 484062 (S)-1-((S)-8-(4'-((tert- butylamino(methyl) biphenyl-3-ylsulfonyl)- l-oxa-8- azaspiro[4.5]decan-3- ylamino)-3-(3-(1- (hydroxymethyl) cyclopropylsulfonyl) phcnoxy)propan-2-ol::US10927123, Compound 240 Beta-3 adrenergic receptor Homo sapiens 31690 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484062 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484062&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225050 443553145 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003258 CCC(C)(C)NCc1ccc(cc1)-c1cccc(c1)S(=O)(=O)N1CCC2(C[C@@H](CO2)NC[C@H](O)COc2cccc(c2)S(=O)(=O)C2(CO)CC2)CC1 InChI=1S/C39H53N3O8S2/c1-4-37(2,3)41-24-29-11-13-30(14-12-29)31-7-5-10-36(21-31)52(47,48)42-19-17-38(18-20-42)23-32(26-50-38)40-25-33(44)27-49-34-8-6-9-35(22-34)51(45,46)39(28-43)15-16-39/h5-14,21-22,32-33,40-41,43-44H,4,15-20,23-28H2,1-3H3/t32-,33-/m0/s1 AIZVEJXGKOPKCT-LQJZCPKCSA-N 484063 (S)-1-(3-(1- (hydroxymelhyl) cyclopropylsulfonyl) phenoxy)-3-((S)-8-(4'- ((tertpentylamino) melhyl)biphenyl-3- ylsulfonyl)-1-oxa-8- azaspiro[4.5]decan-3- ylamino)propan-2-ol::US10927123, Compound 241 Beta-3 adrenergic receptor Homo sapiens 21060 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484063 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484063&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225054 443553146 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003259 OCC1(CC1)S(=O)(=O)c1cccc(OC[C@@H](O)CN[C@@H]2COC3(C2)CCN(CC3)S(=O)(=O)c2cccc(c2)-c2ccc(CN3CCC3)cc2)c1 InChI=1S/C37H47N3O8S2/c41-27-37(12-13-37)49(43,44)34-6-2-5-33(21-34)47-26-32(42)23-38-31-22-36(48-25-31)14-18-40(19-15-36)50(45,46)35-7-1-4-30(20-35)29-10-8-28(9-11-29)24-39-16-3-17-39/h1-2,4-11,20-21,31-32,38,41-42H,3,12-19,22-27H2/t31-,32-/m0/s1 FEJYSMWXFZDMFI-ACHIHNKUSA-N 484064 (S)-1-((S)-8-(4'- (azetidin-1- ylmethyl)biphenyl-3- ylsulfonyl)-1-oxa-8- azaspiro[4.5]decan-3- ylamino)-3-(3-(1- (hydroxymethyl) cyclopropylsulfonyl) phenoxy)propan-2-ol::US10927123, Compound 243 Beta-3 adrenergic receptor Homo sapiens 35010 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484064 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484064&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225270 443553147 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003260 CCCNCc1ccc(cc1)-c1cccc(c1)S(=O)(=O)N1CCC2(C[C@@H](CO2)NC[C@H](O)COc2cccc(c2)S(=O)(=O)C2(CO)CC2)CC1 InChI=1S/C37H49N3O8S2/c1-2-17-38-23-28-9-11-29(12-10-28)30-5-3-8-35(20-30)50(45,46)40-18-15-36(16-19-40)22-31(25-48-36)39-24-32(42)26-47-33-6-4-7-34(21-33)49(43,44)37(27-41)13-14-37/h3-12,20-21,31-32,38-39,41-42H,2,13-19,22-27H2,1H3/t31-,32-/m0/s1 WUMCTULJJWITJC-ACHIHNKUSA-N 484065 (S)-l-(3-(l- (hydroxymethyl) cyclopropylsulfonyl) phcnoxy)-3-((S)-8-(4'- ((propylamino)methyl) biphenyl-3-ylsulfonyl)- 1-oxa-8- azaspiro[4.5]decan-3- ylamino)propan-2-ol::US10927123, Compound 244 Beta-3 adrenergic receptor Homo sapiens 27830 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484065 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484065&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225271 443553148 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003261 CCCCNCc1ccc(cc1)-c1cccc(c1)S(=O)(=O)N1CCC2(C[C@@H](CO2)NC[C@H](O)COc2cccc(c2)S(=O)(=O)C2(CO)CC2)CC1 InChI=1S/C38H51N3O8S2/c1-2-3-18-39-24-29-10-12-30(13-11-29)31-6-4-9-36(21-31)51(46,47)41-19-16-37(17-20-41)23-32(26-49-37)40-25-33(43)27-48-34-7-5-8-35(22-34)50(44,45)38(28-42)14-15-38/h4-13,21-22,32-33,39-40,42-43H,2-3,14-20,23-28H2,1H3/t32-,33-/m0/s1 CZGOTIBAUNXPDM-LQJZCPKCSA-N 484066 (S)-1-((S)-8-(4'- ((butylamino)methyl) biphenyl-3-ylsulfonyl)- 1-oxa-8- azaspiro[4.5]decan-3- ylamino)-3-(3-(1- (hydroxymethyl) cyclopropylsulfonyl) phenoxy)propan-2-ol::US10927123, Compound 245 Beta-3 adrenergic receptor Homo sapiens 18380 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484066 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484066&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225273 443553149 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003262 COCCNCc1ccc(cc1)-c1cccc(c1)S(=O)(=O)N1CCC2(C[C@@H](CO2)NC[C@H](O)COc2cccc(c2)S(=O)(=O)C2(CO)CC2)CC1 InChI=1S/C37H49N3O9S2/c1-47-19-16-38-23-28-8-10-29(11-9-28)30-4-2-7-35(20-30)51(45,46)40-17-14-36(15-18-40)22-31(25-49-36)39-24-32(42)26-48-33-5-3-6-34(21-33)50(43,44)37(27-41)12-13-37/h2-11,20-21,31-32,38-39,41-42H,12-19,22-27H2,1H3/t31-,32-/m0/s1 IRORSWUXZXYAMZ-ACHIHNKUSA-N 484067 (S)-1-(3-(1- (hydroxymethyl) cyclopropylsulfonyl) phenoxy)- 3-((S)-8-(4'-((2- melhoxyethylamino) methyl)biphenyl-3- ylsulfonyl)-1-oxa-8- azaspiro[4.5]decan-3- ylamino)propan-2-ol::US10927123, Compound 247 Beta-3 adrenergic receptor Homo sapiens 33470 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484067 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484067&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225268 443553150 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003263 CCn1cc(c(=O)c2ccccc12)S(=O)(=O)N1CCC2(C[C@@H](CO2)NC[C@@H](O)COc2cccc(c2)S(C)(=O)=O)CC1 InChI=1S/C29H37N3O8S2/c1-3-31-18-27(28(34)25-9-4-5-10-26(25)31)42(37,38)32-13-11-29(12-14-32)16-21(19-40-29)30-17-22(33)20-39-23-7-6-8-24(15-23)41(2,35)36/h4-10,15,18,21-22,30,33H,3,11-14,16-17,19-20H2,1-2H3/t21-,22+/m0/s1 PVXLIOIISUUKOQ-FCHUYYIVSA-N 484068 1-ethyl-3-((S)-3-((R)-2- hydroxy-3-(3- (methylsulfonyl)phenoxy) propylamino)-1-oxa- 8-azaspiro[4.5]decan-8- ylsulfonyl)quinolin- 4(1H)-one::US10927123, Compound 296 Beta-3 adrenergic receptor Homo sapiens 107300 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484068 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484068&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225272 443553151 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003264 CCn1cc(c(=O)c2ccccc12)S(=O)(=O)N1CCC2(C[C@H](CO2)NC[C@H](O)COc2cccc(c2)S(=O)(=O)C2CC2)CC1 InChI=1S/C31H39N3O8S2/c1-2-33-19-29(30(36)27-8-3-4-9-28(27)33)44(39,40)34-14-12-31(13-15-34)17-22(20-42-31)32-18-23(35)21-41-24-6-5-7-26(16-24)43(37,38)25-10-11-25/h3-9,16,19,22-23,25,32,35H,2,10-15,17-18,20-21H2,1H3/t22-,23+/m1/s1 AAWVWMAALFDCKX-PKTZIBPZSA-N 484069 3-((R)-3-((S)-3-(3- (cyclopropylsulfonyl) phenoxy)-2- hydroxypropylamino)- 1-oxa-8- azaspiro[4.5]decan-8- ylsulfonyl)-1- ethylquinolin-4(1H)-one::US10927123, Compound 297 Beta-3 adrenergic receptor Homo sapiens 26500 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484069 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484069&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225060 443553152 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003265 OCC1(CC1)S(=O)(=O)c1cccc(OC[C@@H](O)CN[C@H]2COC3(C2)CCN(CC3)S(=O)(=O)c2ccc3ccccc3c2)c1 InChI=1S/C31H38N2O8S2/c34-22-31(10-11-31)42(36,37)28-7-3-6-27(17-28)40-21-26(35)19-32-25-18-30(41-20-25)12-14-33(15-13-30)43(38,39)29-9-8-23-4-1-2-5-24(23)16-29/h1-9,16-17,25-26,32,34-35H,10-15,18-22H2/t25-,26+/m1/s1 SFDPMSWBGNUFHL-FTJBHMTQSA-N 484070 (S)-1-(3-(1- (hydroxymethyl) cyclopropylsulfonyl) phenoxy)- 3-((R)-8-(naphthalen-2- ylsulfonyl)-1-oxa-8- azaspiro[4.5]decan-3- ylamino)propan-2-ol::US10927123, Compound 300 Beta-3 adrenergic receptor Homo sapiens 20390 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484070 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484070&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225055 443553153 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003266 O[C@@H](CN[C@H]1COC2(C1)CCN(CC2)S(=O)(=O)c1ccc2cc[nH]c2c1)COc1cccc(c1)S(=O)(=O)C1CC1 484071 (S)-1-((R)-8-(1H- pyrrolo[3,2-b]pyridin-6- ylsulfonyl)-1-oxa-8- azaspiro[4.5]decan-3- ylamino)-3-(3- (cyclopropylsulfonyl) phenoxy)propan-2-ol::US10927123, Compound 309 Beta-3 adrenergic receptor Homo sapiens 7003 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484071 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484071&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 155076532 443553154 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003267 CCn1cc(c(=O)c2ccccc12)S(=O)(=O)N1CCC2(C[C@H](CO2)NC[C@H](O)COc2cccc(c2)S(C)(=O)=O)CC1 InChI=1S/C29H37N3O8S2/c1-3-31-18-27(28(34)25-9-4-5-10-26(25)31)42(37,38)32-13-11-29(12-14-32)16-21(19-40-29)30-17-22(33)20-39-23-7-6-8-24(15-23)41(2,35)36/h4-10,15,18,21-22,30,33H,3,11-14,16-17,19-20H2,1-2H3/t21-,22+/m1/s1 PVXLIOIISUUKOQ-YADHBBJMSA-N 484072 1-ethyl-3-((R)-3-((S)-2- hydroxy-3-(3- (methylsulfonyl)phenoxy) propylamino)-1-oxa- 8-azaspiro[4.5]decan-8- ylsulfonyl)quinolin- 4(1H)-one::US10927123, Compound 310 Beta-3 adrenergic receptor Homo sapiens 37650 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484072 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484072&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225057 443553155 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003268 CS(=O)(=O)c1cccc(OC[C@@H](O)CN[C@H]2COC3(C2)CCN(CC3)S(=O)(=O)c2cnc3cc[nH]c3c2)c1 484073 (S)-1-((R)-8-(1H- pyrrolo[3,2-b]pyridin-6- ylsulfonyl)-1-oxa-8- azaspiro[4.5]decan-3- ylamino)-3-(3- (mcthylsulfonyl)phenoxy) propan-2-ol::US10927123, Compound 320::US10927123, Compound 321 Beta-3 adrenergic receptor Homo sapiens 11180 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484073 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484073&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225058 443553156 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003269 CS(=O)(=O)c1cccc(OC[C@@H](O)CN[C@H]2COC3(C2)CCN(CC3)S(=O)(=O)c2cnc3cc[nH]c3c2)c1 484073 (S)-1-((R)-8-(1H- pyrrolo[3,2-b]pyridin-6- ylsulfonyl)-1-oxa-8- azaspiro[4.5]decan-3- ylamino)-3-(3- (mcthylsulfonyl)phenoxy) propan-2-ol::US10927123, Compound 320::US10927123, Compound 321 Beta-3 adrenergic receptor Homo sapiens 17830 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484073 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484073&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225058 443553156 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003270 CCn1cc(c(=O)c2cccc(F)c12)S(=O)(=O)N1CCC2(C[C@H](CO2)NC[C@H](O)COc2cccc(c2)S(C)(=O)=O)CC1 InChI=1S/C29H36FN3O8S2/c1-3-32-17-26(28(35)24-8-5-9-25(30)27(24)32)43(38,39)33-12-10-29(11-13-33)15-20(18-41-29)31-16-21(34)19-40-22-6-4-7-23(14-22)42(2,36)37/h4-9,14,17,20-21,31,34H,3,10-13,15-16,18-19H2,1-2H3/t20-,21+/m1/s1 BKRHXZUEUCCODF-RTWAWAEBSA-N 484075 1-ethyl-8-fluoro-3-((R)- 3-((S)-2-hydroxy-3-(3- (methylsulfonyl)phenoxy) propylamino)-1-oxa- 8-azaspiro[4.5]decan-8- ylsulfonyl)quinolin- 4(1H)-one::US10927123, Compound 322 Beta-3 adrenergic receptor Homo sapiens 21770 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484075 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484075&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225061 443553157 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003271 O[C@@H](CN[C@H]1COC2(C1)CCN(CC2)S(=O)(=O)c1c[nH]c2ccccc2c1=O)COc1cccc(c1)S(=O)(=O)C1CC1 484076 3-((R)-3-((S)-3-(3- (cyclopropylsulfonyl) phenoxy)-2- hydroxypropylamino)-1- oxa-8-azaspiro[4.5]decan- 8-ylsulfonyl)quinolin- 4(1H)-one::US10927123, Compound 326 Beta-3 adrenergic receptor Homo sapiens 17260 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484076 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484076&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156596250 443553158 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003272 Cc1cccc2c(O)c(cnc12)S(=O)(=O)N1CCC2(C[C@H](CO2)NC[C@H](O)COc2cccc(c2)S(=O)(=O)C2CC2)CC1 InChI=1S/C30H37N3O8S2/c1-20-4-2-7-26-28(20)32-17-27(29(26)35)43(38,39)33-12-10-30(11-13-33)15-21(18-41-30)31-16-22(34)19-40-23-5-3-6-25(14-23)42(36,37)24-8-9-24/h2-7,14,17,21-22,24,31,34H,8-13,15-16,18-19H2,1H3,(H,32,35)/t21-,22+/m1/s1 XYIBFCSTTYQYHQ-YADHBBJMSA-N 484077 3-((R)-3-((S)-3-(3- (cyclopropylsulfonyl) phenoxy)-2- hydroxypropylamino)-1- oxa-8-azaspiro[4.5]decan- 8-ylsulfonyl)-8- methylquinolin-4-ol::US10927123, Compound 327 Beta-3 adrenergic receptor Homo sapiens 28920 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484077 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484077&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225269 443553159 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003273 O[C@@H](CN[C@H]1COC2(C1)CCN(CC2)S(=O)(=O)c1cnc2cc(F)ccc2c1O)COc1cccc(c1)S(=O)(=O)C1CC1 InChI=1S/C29H34FN3O8S2/c30-19-4-7-25-26(12-19)32-16-27(28(25)35)43(38,39)33-10-8-29(9-11-33)14-20(17-41-29)31-15-21(34)18-40-22-2-1-3-24(13-22)42(36,37)23-5-6-23/h1-4,7,12-13,16,20-21,23,31,34H,5-6,8-11,14-15,17-18H2,(H,32,35)/t20-,21+/m1/s1 XHTFCTRDBRTXGB-RTWAWAEBSA-N 484078 3-((R)-3-((S)-3-(3- (cyclopropylsulfonyl) phenoxy)-2- hydroxypropylamino)-1- oxa-8-azaspiro[4.5]decan- 8-ylsulfonyl)- 7-fluoroquinolin-4-ol::US10927123, Compound 329 Beta-3 adrenergic receptor Homo sapiens 29490 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484078 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484078&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225267 443553160 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4 1003274 CCn1cc(c(=O)c2cccc(F)c12)S(=O)(=O)N1CCC2(C[C@H](CO2)NC[C@H](O)COc2cccc(c2)S(=O)(=O)C(C)C)CC1 InChI=1S/C31H40FN3O8S2/c1-4-34-18-28(30(37)26-9-6-10-27(32)29(26)34)45(40,41)35-13-11-31(12-14-35)16-22(19-43-31)33-17-23(36)20-42-24-7-5-8-25(15-24)44(38,39)21(2)3/h5-10,15,18,21-23,33,36H,4,11-14,16-17,19-20H2,1-3H3/t22-,23+/m1/s1 YCJFEWANNWEZDY-PKTZIBPZSA-N 484079 1-ethyl-8-fluoro-3-((R)- 3-((S)-2-hydroxy-3-(3- (isopropylsulfonyl) phenoxy)propylamino)- 1-oxa-8- azaspiro[4.5]decan-8- ylsulfonyl)quinolin- 4(1H)-one::US10927123, Compound 331 Beta-3 adrenergic receptor Homo sapiens 30040 US Patent 10.7270/Q2D221QM aid1805292 US10927123 Tran, T; Do, Q; Ullman, B; Blackburn, AC; Nagura, M 2/23/2021 9/6/2021 Arena Pharmaceuticals, Inc. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=484079 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2890&target=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=484079&enzyme=Beta-3+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 132225266 443553161 1 MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS Beta-3 adrenergic receptor ADRB3_HUMAN P13945 Q4JFT4